Haemolytic uraemic syndrome after living-donor liver transplantation: is small-for-size graft a potential risk factor?

J Int Med Res. 2008 May-Jun;36(3):599-604. doi: 10.1177/147323000803600328.

Abstract

Haemolytic uraemic syndrome (HUS) is a rare complication of solid organ transplantation. Immunosuppressive drugs, including cyclosporin A and tacrolimus, have frequently been incriminated. Here we report a case of tacrolimus-induced HUS in a woman with small-for-size syndrome after living-donor liver transplantation. Hypertension, microangiopathic anaemia and end-stage renal failure occurred in the immediate post-transplant period; all other risk factors that might be implicated in the development of HUS were investigated and excluded if no evidence was found. A possible association between small-for-size syndrome, which frequently results in a high blood concentration of tacrolimus post-operatively, and the occurrence of HUS is discussed.

Publication types

  • Case Reports

MeSH terms

  • Female
  • Hemolytic-Uremic Syndrome / etiology*
  • Humans
  • Liver Transplantation / adverse effects*
  • Living Donors*
  • Middle Aged
  • Risk Factors